1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > Germany Immuno Chemistry Market Outlook to 2021

Germany Immuno Chemistry Market Outlook to 2021

  • September 2015
  • -
  • Global Data
  • -
  • 87 pages

Germany Immuno Chemistry Market Outlook to 2021

Summary

GlobalData’s new report, "Germany Immuno Chemistry Market Outlook to 2021", provides key market data on the Germany Immuno Chemistry market. The report provides value, in millions of US dollars within market segments - Anemia Tests, Vitamins Tests, Disease Specific Immunochemistry, Endocrinology Tests, Immunochemistry Analyzers, Immunochemistry Rapid Tests & POC, IgE Allergy Blood Tests and Specific Proteins.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Immuno Chemistry market includes Anemia Tests, Vitamins Tests, Disease Specific Immunochemistry, Endocrinology Tests, Immunochemistry Analyzers, Immunochemistry Rapid Tests & POC, IgE Allergy Blood Tests and Specific Proteins.
- Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Immuno Chemistry market.
- Global corporate-level profiles of key companies operating within the Germany Immuno Chemistry market.
- Key players covered include Siemens Healthcare, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Alere Inc., Ortho-Clinical Diagnostics Inc. and Abbott Laboratories.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table Of Contents

Germany Immuno Chemistry Market Outlook to 2021
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 5
2 Introduction 6
2.1 What Is This Report About? 6
2.2 Immuno Chemistry Market Segmentation 6
2.3 Definitions of Markets Covered in the Report 7
3 Immuno Chemistry Market, Germany 12
3.1 Immuno Chemistry Market, Germany, Revenue ($m), 2007-2014 12
3.2 Immuno Chemistry Market, Germany, Revenue ($m), 2014-2021 14
3.2.1 Anemia Tests Market, Germany, Revenue ($m), by Segment, 2007-2014 16
3.2.2 Disease Specific Immunochemistry Market, Germany, Revenue ($m), by Segment, 2007-2014 18
3.2.3 Endocrinology Tests Market, Germany, Revenue ($m), by Segment, 2007-2014 20
3.2.4 IgE Allergy Blood Tests Market, Germany, Revenue ($m), by Segment, 2007-2014 22
3.2.5 Immunochemistry Analyzers Market, Germany, Revenue ($m), by Segment, 2007-2014 24
3.2.6 Immunochemistry Rapid Tests and POC Market, Germany, Revenue ($m), by Segment, 2007-2014 26
3.2.7 Vitamins Tests Market, Germany, Revenue ($m), by Segment, 2007-2014 28
3.2.8 Anemia Tests Market, Germany, Revenue ($m), by Segment, 2014-2021 30
3.2.9 Disease Specific Immunochemistry Market, Germany, Revenue ($m), by Segment, 2014-2021 32
3.2.10 Endocrinology Tests Market, Germany, Revenue ($m), by Segment, 2014-2021 34
3.2.11 IgE Allergy Blood Tests Market, Germany, Revenue ($m), by Segment, 2014-2021 36
3.2.12 Immunochemistry Analyzers Market, Germany, Revenue ($m), by Segment, 2014-2021 38
3.2.13 Immunochemistry Rapid Tests and POC Market, Germany, Revenue ($m), by Segment, 2014-2021 40
3.2.14 Vitamins Tests Market, Germany, Revenue ($m), by Segment, 2014-2021 42
3.3 Immuno Chemistry Market, Germany, Distribution Share by Revenue ($m), 2013-2014 44
3.4 Immuno Chemistry Market, Germany, Company Share by Revenue ($m), 2014 45
4 Overview of Key Companies in Germany, Immuno Chemistry Market 47
4.1 Siemens Healthcare 47
4.1.1 Company Overview 47
4.2 F. Hoffmann-La Roche Ltd. 47
4.2.1 Company Overview 47
4.3 Abbott Laboratories 47
4.3.1 Company Overview 47
4.4 Bio-Rad Laboratories, Inc. 48
4.4.1 Company Overview 48
4.5 Ortho-Clinical Diagnostics Inc. 48
4.5.1 Company Overview 48
4.6 bioMerieux S.A. 48
4.6.1 Company Overview 48
4.7 PerkinElmer, Inc. 49
4.7.1 Company Overview 49
4.8 Alere Inc. 49
4.8.1 Company Overview 49
4.9 Euroimmun AG 50
4.9.1 Company Overview 50
5 Immuno Chemistry Market Pipeline Products 51
6 Financial Deals Landscape 57
6.1 Equity Offerings 57
6.1.1 Epigenomics Raises USD5.6 Million in Rights Offering of Shares 57
6.2 Partnerships 58
6.2.1 Protagen Enters into Agreement with Qiagen to Develop Novel Protein-Based Companion Diagnostics 58
6.2.2 Abcam Enters into Co-Marketing Agreement with Cell Marque for IVD IHC RabMAb Antibodies 59
7 Recent Developments 60
7.1 Corporate Communications 60
7.1.1 Apr 23, 2015: apceth Names Ulrike Verzetnitsch as Chief Technical Officer 60
7.1.2 Mar 20, 2015: First blood test for osteoarthritis could soon be available 60
7.2 Financial Announcements 61
7.2.1 Aug 06, 2015: Epigenomics Announces Q2 2015 and 6M 2015 Financial Results and Reports on Operational Highlights 61
7.2.2 Jul 29, 2015: Fresenius Medical Care Reports Second Quarter 2015 Results And Confirms Guidance For Full Year 2015 63
7.2.3 May 12, 2015: Epigenomics Announces Q1 2015 Financial Results and Reports on Operational Highlights 65
7.2.4 Apr 29, 2015: Fresenius Medical Care reports first quarter 2015 results and confirms guidance for full year 2015 67
7.2.5 Mar 26, 2015: Eckert and Ziegler's Annual Report 2014: Weak Therapy segment puts a strain on consolidated profit 67
7.2.6 Mar 25, 2015: Epigenomics Reports Results for the Financial Year Ended December 31, 2014 and Provides Outlook for 2015 68
7.2.7 Mar 02, 2015: Shire Submits Application to the U.S. FDA for Approval of Lifitegrast For Treatment of Dry Eye Disease in Adults 70
7.2.8 Feb 25, 2015: Fresenius Medical Care reports fourth quarter and full year 2014 results 73
7.2.9 Nov 11, 2014: Epigenomics Announces 2014 Third Quarter and Nine Month Financial Results and Reports on Operational Highlights 76
7.2.10 Nov 04, 2014: Fresenius Posts Strong Q3 Results And Confirms 2014 Group Outlook 78
7.3 Legal And Regulatory 80
7.3.1 Jun 22, 2015: apceth Expands Further its GMP Manufacturing Business 80
7.4 Other Significant Developments 80
7.4.1 Aug 12, 2015: Merck Millipore Announces Charitable Contribution to Massachusetts Institute of Technology for Development of Novel Ebola Diagnostic and Tracking Platform 80
7.4.2 Jan 16, 2015: Agilent Technologies Names Alacris Theranostics as Certified Provider of Target Enrichment Services 81
7.5 Product News 81
7.5.1 Jun 22, 2015: New 3D test system for breast cancer radiosensitizing drugs 81
7.6 Research And Development 82
7.6.1 Oct 30, 2014: Novocure Enrolls First Patient In A Pilot Study of Tumor Treating Fields Together With Paclitaxel For The Treatment Of Recurrent Ovarian Cancer 82
8 Appendix 84
8.1 Research Methodology 85
8.1.1 Coverage 85
8.1.2 Secondary Research 85
8.1.3 Primary Research 85
8.1.4 Company Share Analysis 86
8.1.5 Distribution Share Analysis 86
8.2 GlobalData Consulting 86
8.3 Contact Us 86
8.4 Disclaimer 87

1.1 List of Tables
Table 1: Immuno Chemistry Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 13
Table 2: Immuno Chemistry Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 15
Table 3: Anemia Tests Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 17
Table 4: Disease Specific Immunochemistry Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 19
Table 5: Endocrinology Tests Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 21
Table 6: IgE Allergy Blood Tests Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 23
Table 7: Immunochemistry Analyzers Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 25
Table 8: Immunochemistry Rapid Tests and POC Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 27
Table 9: Vitamins Tests Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 29
Table 10: Anemia Tests Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 31
Table 11: Disease Specific Immunochemistry Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 33
Table 12: Endocrinology Tests Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 35
Table 13: IgE Allergy Blood Tests Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 37
Table 14: Immunochemistry Analyzers Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 39
Table 15: Immunochemistry Rapid Tests and POC Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 41
Table 16: Vitamins Tests Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 43
Table 17: Immuno Chemistry Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2013-2014 44
Table 18: Immuno Chemistry Market, Germany, Company Share by Revenue ($m), USD Constant, 2014 46
Table 19: Immuno Chemistry Market Pipeline Products 51
Table 20: Epigenomics Raises USD5.6 Million in Rights Offering of Shares 57
Table 21: Protagen Enters into Agreement with Qiagen to Develop Novel Protein-Based Companion Diagnostics 58
Table 22: Abcam Enters into Co-Marketing Agreement with Cell Marque for IVD IHC RabMAb Antibodies 59

1.2 List of Figures
Figure 1: Immuno Chemistry Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 12
Figure 2: Immuno Chemistry Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 14
Figure 3: Anemia Tests Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 16
Figure 4: Disease Specific Immunochemistry Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 18
Figure 5: Endocrinology Tests Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 20
Figure 6: IgE Allergy Blood Tests Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 22
Figure 7: Immunochemistry Analyzers Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 24
Figure 8: Immunochemistry Rapid Tests and POC Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 26
Figure 9: Vitamins Tests Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 28
Figure 10: Anemia Tests Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 30
Figure 11: Disease Specific Immunochemistry Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 32
Figure 12: Endocrinology Tests Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 34
Figure 13: IgE Allergy Blood Tests Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 36
Figure 14: Immunochemistry Analyzers Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 38
Figure 15: Immunochemistry Rapid Tests and POC Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 40
Figure 16: Vitamins Tests Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 42
Figure 17: Immuno Chemistry Market, Germany, Company Share (%) 2014 45

Companies Mentioned
Siemens Healthcare
F. Hoffmann-La Roche Ltd.
Abbott Laboratories
Bio-Rad Laboratories, Inc.
Ortho-Clinical Diagnostics Inc.
bioMerieux S.A.
PerkinElmer, Inc.
Alere Inc.
Euroimmun AG

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Competing in the Global Enteric Disease Testing Market

2016 Competing in the Global Enteric Disease Testing Market

  • $ 11500
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...

Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

  • $ 7500
  • Industry report
  • September 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...

World Enteric Diseases Diagnostic Testing Market Future Horizons and Growth Strategies: Supplier Shares by Test, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities

World Enteric Diseases Diagnostic Testing Market Future Horizons and Growth Strategies: Supplier Shares by Test, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities

  • $ 7500
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.